Literature DB >> 17392871

Rapid regression of disc and retinal neovascularization in a case of Eales disease after intravitreal bevacizumab.

Atul Kumar, Subijay Sinha.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392871     DOI: 10.3129/can j ophthalmol.i07-026

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


× No keyword cloud information.
  13 in total

1.  Secondary rhegmatogenous retinal detachment following intravitreal bevacizumab in patients with vitreous hemorrhage or tractional retinal detachment secondary to Eales' disease.

Authors:  Atul Kumar; Sri Vatsa Sehra; M B Thirumalesh; Varun Gogia
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-15       Impact factor: 3.117

2.  Combination of intravitreal bevacizumab and peripheral photocoagulation: an alternative treatment in eales disease.

Authors:  Juarez Cp; Gramajo Al; Luna Jd
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2013

3.  Intravitreal bevacizumab to facilitate vitrectomy in idiopathic ischaemic retinal vasculitis.

Authors:  Roger Wong; Bhaskar Gupta; Miles R Stanford; D Alistair H Laidlaw
Journal:  Int Ophthalmol       Date:  2009-12-10       Impact factor: 2.031

4.  Intravitreal bevacizumab: an analysis of the evidence.

Authors:  Derrick P Smit; David Meyer
Journal:  Clin Ophthalmol       Date:  2007-09

5.  [Intraocular injections of bevacizumab in rare indications--two cases].

Authors:  T Wecke; C Knop; W Schreiber; W Behrens-Baumann
Journal:  Ophthalmologe       Date:  2009-05       Impact factor: 1.059

6.  Intra-ocular expression of vascular endothelial growth factor (VEGF) and pigment epithelial-derived factor (PEDF) in a case of Eales' disease by immunohistochemical analysis: a case report.

Authors:  Aditya Verma; Jyotirmay Biswas; Selvi Radhakrishnan; Angayarkanni Narayanasamy
Journal:  Int Ophthalmol       Date:  2010-01-05       Impact factor: 2.031

7.  Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease.

Authors:  Narayanasamy Angayarkanni; Radhakrishnan Selvi; Rishi Pukhraj; Jyotirmoy Biswas; Shah J Bhavesh; Joyce Tombran-Tink
Journal:  J Ocul Biol Dis Infor       Date:  2009-03-06

8.  Rapid regression of exudative maculopathy in idiopathic retinitis, vasculitis, aneurysms and neuroretinitis syndrome after intravitreal ranibizumab.

Authors:  Cristina Marín-Lambíes; Roberto Gallego-Pinazo; David Salom; Javier Navarrete; Manuel Díaz-Llopis
Journal:  Case Rep Ophthalmol       Date:  2012-08-15

9.  Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization.

Authors:  Ahmad M Mansour; Friederike Mackensen; Padmamalini Mahendradas; Moncef Khairallah; Timothy Yy Lai; Ziad Bashshur
Journal:  Clin Ophthalmol       Date:  2012-08-01

10.  Eales' disease - current concepts in diagnosis and management.

Authors:  Jyotirmay Biswas; Reesha Karingattil Ravi; Angayarkanni Naryanasamy; Lily Therese Kulandai; Hajib Naraharirao Madhavan
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.